PRA International has completed its merger with ReSearch Pharmaceutical Services (RPS) creating the fourth largest CRO, and offering an expanded portfolio of services and capabilities. RPS will operate as PRA’s Strategic Solutions Division. PRA’s chief executive officer Colin Shannon will lead the combined enterprise. Former RPS chief executive officer Harris Koffer and president Samir Shah have been named president and chief operating officer of the Strategic Solutions Division, respectively.
 
Mr. Shannon commented, “As we join forces with the team at RPS, this begins a new chapter for both organizations. We have a supportive long-term partner in KKR and the combination with RPS makes PRA a stronger organization, offering our customers a more comprehensive range of services through our expanded capabilities and therapeutic expertise. As a division of PRA, the RPS Strategic Solutions Division will continue to operate as RPS has previously, which should enable a seamless integration with absolutely no disruption for our clients.”
 
Mr. Koffer added, “We are excited about joining the PRA family and leveraging the enhanced capabilities of the combined company to deliver greater value and innovation for our clients and employees.”